Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.26
(
0.05%
)
Bitcoin
78,445.09
(
0.21%
)
News Focus
News Focus
Post# of 822647
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4176
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: Doc logic post# 528595

Sunday, 11/06/2022 11:44:23 PM

Sunday, November 06, 2022 11:44:23 PM

Post# of 822647
UK approval would gave limited revenue -- NICE would force deep discounts. FDA dates are what counts for the future of NWBO.

NWBO has made no statement claiming they have rolling application for the FDA. They have also stated in their SEC filing that no applications have been filed. And NWBO certainly doesn't move fast -- 16 years to run a trial, 19 months to analyze data.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News